{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sickle-cell-disease/diagnosis/assessment-of-acute-crisis/","result":{"pageContext":{"chapter":{"id":"ed48dbda-a404-50cf-a290-86fafcdb9908","slug":"assessment-of-acute-crisis","fullItemName":"Assessment of acute crisis","depth":2,"htmlHeader":"<!-- begin field 6e57a16d-312f-43a9-8d28-63e970f2ed97 --><h2>How should I assess a person with an acute sickle cell crisis?</h2><!-- end field 6e57a16d-312f-43a9-8d28-63e970f2ed97 -->","summary":"","htmlStringContent":"<!-- begin item 8b10fe07-7720-4ca3-b187-86dfb4c0c822 --><!-- begin field f59912a5-e2b1-48d7-bccd-be68943a9586 --><p><strong>If an acute sickle cell crisis is <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/diagnosis/when-to-suspect-an-acute-sickle-cell-crisis/\">suspected</a></strong><strong>:</strong></p><ul><li><strong>Take a history. </strong>Ask about clinical features of the <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute complications</a> of sickle cell disease, such as:<ul><li><strong>Pain in the bones and joints</strong><ul><li>Painful, swollen joints may be due to acute bone infarction during an <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute pain crisis</a>, or septic arthritis.</li><li>An infant may present with dactylitis (painful swelling of the bones of the hands and feet).</li><li>Consider the possibility of <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute osteomyelitis</a>, although pain is more likely to be caused by an acute pain crisis than by osteomyelitis.</li></ul></li><li><strong>Abdominal pain</strong><ul><li>Consider the <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">causes of abdominal pain</a> that are common in people with sickle cell disease, as well as general surgical pathology. </li><li>Consider that pain may be secondary to <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">gallstones</a> (which are very common), ascending cholangitis, acute cholecystitis, gallbladder empyema, or acute pancreatitis.</li><li>An abdominal sickle crisis is often indistinguishable from an acute abdomen due to a surgical cause.</li><li>A large and tender liver, pallor, abdominal distension, and circulatory collaspse (infrequent) may be caused by <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute hepatic sequestration</a>.</li></ul><ul></ul></li><li><strong>Fever</strong><ul><li>A crisis may also be associated with an <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute febrile illness</a> due to infection.</li><li>Fever may present alone or may accompany an acute painful crisis with no signs of infection.</li><li>Children younger than 5 years of age are particularly at risk of pneumococcal infection.</li></ul></li><li><strong>Breathlessness</strong><ul><li>Chest pain and breathlessness occur in <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">acute chest syndrome</a>. </li></ul></li><li><strong>Symptoms of a stroke</strong><ul><li>An acute stroke due to ischaemia may occur at any age but is common in children. The incidence increases with age in adults older than 30 years of age (adults aged 20–29 years are more likely to have a subarachnoid or intracerebral haemorrhage).</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">Neurological complications</a> of a sickle cell crisis may also present as hemparesis, speech problems, seizures, or altered consciousness.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">Acute renal failure</a><ul><li>This may be precipitated by dehydration and sepsis.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">Acute priapism</a><ul><li>Ask about the length of time since the onset.</li><li>Acute priapism becomes an emergency if it has been present for more than 3 hours.</li></ul></li></ul></li><li><strong>Examine the person. </strong><ul><li>Examine for painful, swollen joints.</li><li>Check the person's temperature.</li><li>Check the person's pallor.<ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">Acute splenic sequestration</a> may present with shock or severe pallor. Because it is most common in young children, parents are taught to palpate the spleen, and they may report an acute increase in splenic size.</li><li>Development of severe pallor over several days owing to anaemia occurs in <a class=\"topic-reference internal-reference\" href=\"/topics/sickle-cell-disease/background-information/complications/#acute-complications\">transient red cell aplasia</a> and is due to parvovirus infection. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/parvovirus-b19-infection/\">Parvovirus B19 infection</a> for more information.</li></ul></li><li>Palpate for splenomegaly. <ul><li>On examination, there may be significant splenomegaly, but this resolves by the end of the first decade of life because of multiple splenic infarcts.</li></ul></li></ul></li></ul><!-- end field f59912a5-e2b1-48d7-bccd-be68943a9586 --><!-- end item 8b10fe07-7720-4ca3-b187-86dfb4c0c822 -->","topic":{"id":"eb346bd0-1df2-5db2-a583-a366e34cfc19","topicId":"cc107f5d-efe6-4625-840e-5c4d4656869b","topicName":"Sickle cell disease","slug":"sickle-cell-disease","lastRevised":"Last revised in November 2016","chapters":[{"id":"d2b6d668-4d29-5c50-b65d-7467cbcce2dd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"47f9af8d-8bda-55a3-bf81-eb75a7c4f02a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4a0ece3e-fa44-5ecd-9f55-ac17384d960c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"44a5b5f9-fc8e-5024-87e3-a7e42dca3dd9","slug":"changes","fullItemName":"Changes"},{"id":"48757ec5-731a-57fd-8e39-d2cdf918179a","slug":"update","fullItemName":"Update"}]},{"id":"53ae2089-f545-5b24-99c5-a9fc620ea575","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ffff20e4-5bc5-5c3b-bb59-858dba2fcf8d","slug":"goals","fullItemName":"Goals"},{"id":"16f85d1d-aec7-5173-9e0b-7d9456bdf3a5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12a41d5f-f447-5a64-868a-7648c7de9355","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5de2a0f3-a77d-5244-a401-dbd2cbcfefb3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fc893fb4-51ec-5705-8dff-c7fba1969646","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cc1cc5c4-df13-5e74-bde0-9f625ec4d1cf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"02e2bd4f-75cd-5b59-9a81-c06d3bcf4d2f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2a8eb5f7-6691-505b-bd86-9620102057a3","slug":"definition","fullItemName":"Definition"},{"id":"b756c83a-dcc0-5792-b3f9-fa9416929ce3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"488c0ab1-f1c0-5fbf-bd1e-e327181c2e1f","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b62a5aae-0dc3-5ac0-a1b1-d3ca0a7969ac","slug":"complications","fullItemName":"Complications"}]},{"id":"9336c0e7-d5d3-5dd6-99fd-50610ced96e1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dd5a2bec-36ce-58c0-b0f1-4ec5d4d17c21","slug":"when-to-suspect-sickle-cell-disease","fullItemName":"When to suspect sickle cell disease"},{"id":"bdbf4e2a-7a0c-5a2e-8b9c-4a9c661409ef","slug":"diagnosis-of-sickle-cell-disease","fullItemName":"Diagnosis of sickle cell disease"},{"id":"68746f0d-607a-5db5-8949-a87a4ed29328","slug":"when-to-suspect-an-acute-sickle-cell-crisis","fullItemName":"When to suspect an acute sickle cell crisis"},{"id":"ed48dbda-a404-50cf-a290-86fafcdb9908","slug":"assessment-of-acute-crisis","fullItemName":"Assessment of acute crisis"}]},{"id":"221fb88b-b951-5835-b282-ed218b637ff0","fullItemName":"Management","slug":"management","subChapters":[{"id":"e76854fe-5d45-5d85-8591-5712daa7e4d9","slug":"screening","fullItemName":"Scenario: Screening"},{"id":"1da4d393-99a4-51c1-b354-f1742b9d8b1f","slug":"management-sickle-cell-crisis","fullItemName":"Scenario: Management - sickle cell crisis"},{"id":"2bf8553c-1641-5bdc-bbc3-2615ddc5b84c","slug":"management-chronic-complications","fullItemName":"Scenario: Management - chronic complications"},{"id":"4493185d-8907-5325-a195-a7cd7039bd68","slug":"prevention-of-complications","fullItemName":"Scenario: Prevention of complications"},{"id":"2aeac855-0e31-598c-804d-41c8d9bc643f","slug":"management-sickle-cell-trait","fullItemName":"Scenario: Management - sickle cell trait"},{"id":"5b85ac92-9286-564f-88fb-ec37a6f4102e","slug":"contraception","fullItemName":"Scenario: Contraception"}]},{"id":"a424bf70-c56c-54a4-a2e2-019ab7c27c69","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"515607d5-c2e2-5a4c-8d83-1bb5e320badf","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2148be5b-6502-5e45-b86b-e552aa3226fd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"acc3b704-7f3d-51ed-869e-38e0309c53e5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2a46384b-d43c-536a-9a17-4b8953d8457a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"46873f42-ab32-5894-b2fe-429a4e62161b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1dd24310-b8ac-5381-b51a-ca1f6c178d72","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7405fe0a-8432-5e64-9fe0-4d112fd89232","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9336c0e7-d5d3-5dd6-99fd-50610ced96e1","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"27b028c8-e872-5dd4-8788-2b22e436c01e","slug":"basis-for-recommendation-678","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 60df5b59-0b86-4a23-9261-a6b9017e4962 --><h3>Basis for recommendation</h3><!-- end field 60df5b59-0b86-4a23-9261-a6b9017e4962 -->","summary":null,"htmlStringContent":"<!-- begin item 678eef20-3ee5-4345-b6c1-a6b9017e46ca --><!-- begin field acd954f6-e180-4282-88b2-a6b9017e4962 --><p>These recommendations are based largely on expert opinion in the guidelines <em>Sickle cell disease in childhood: standards and guidelines for clinical care</em> published by the NHS Sickle Cell and Thalassaemia Screening Programme in partnership with the Sickle Cell Society [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>] and <em>Standards for the clinical care of adults with sickle cell disease in the UK </em>published by the Sickle Cell Society [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>].</p><h4>History and examination</h4><ul><li>Expert opinion in the <em>Standards for the clinical care of adults with sickle cell disease in the UK</em> is that on emergency presentation, people with sickle cell disease should be assessed for acute and potentially life-threatening complications, including infection, acute chest syndrome, neurological problems, acute renal failure, and priapism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>].</li></ul><h4>Priapism as a medical emergency</h4><ul><li>The time that is required to elapse before priapism is considered to be a medical emergency differs slightly between guideline groups:<ul><li>Expert opinion in the guideline<em> Sickle cell disease in childhood: standards and guidelines for clinical care</em> is that acute priapism becomes an emergency after 3 hours [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">PHE, 2010</a>].</li><li>Expert opinion in <em>Standards for the clinical care of adults with sickle cell disease in the UK</em> is that acute priapism becomes an emergency after 4 hours [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sickle-cell-disease/references/\">Sickle Cell Society, 2008</a>].</li></ul></li><li>Due to the risk of cavernosal fibrosis and impotence (which are serious and potentially permanent consequences of a prolonged, untreated attack of priapism), CKS recommends that the shorter time of 3 hours should be considered a medical emergency.</li></ul><!-- end field acd954f6-e180-4282-88b2-a6b9017e4962 --><!-- end item 678eef20-3ee5-4345-b6c1-a6b9017e46ca -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}